214610 — The BioMed Co Share Price
0.000.00%
Last trade - 00:00- KR₩23bn
- KR₩30bn
- KR₩5bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.87 | ||
| Price to Tang. Book | 1.17 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.87 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -50.97% | ||
| Return on Equity | -89.28% | ||
| Operating Margin | -445.08% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 45,671.91 | 30,302.08 | 16,111.43 | 5,367.42 | 4,640.1 | n/a | n/a | 2.52% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
The BioMed Co Ltd, formerly MiCo BioMed Co Ltd, is a Korea-based company mainly engaged in the development of in-vitro diagnostic (IVD) medical equipment and devices. The Company operates its business through five segments. The Molecular Diagnosis segment mainly manufactures and sells products such as molecular diagnostic equipment, gene amplification equipment, reagents, and lab chips. The Biochemical Diagnosis segment mainly manufactures and supplies products such as complex diagnostic, anemia measuring, blood glucose measuring equipment, medical devices and strips. The Immunodiagnostic Business segment mainly produces and sells immunodiagnostic devices and immunodiagnostic kits. The Education Business segment mainly provides BtoC services that occur when customers use boarding schools and BtoB services that occur when the Company provides content to external schools. The Other Business segment mainly manufactures and sells pain relief electrical stimulation devices.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 6th, 2009
- Public Since
- June 22nd, 2015
- No. of Shareholders
- 20,420
- No. of Employees
- 85
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 5,149,628
- Address
- 3F, 4F, Ga Dong, LH Corporate, SEONGNAM, 13449
- Web
- https://www.micobiomed.com/
- Phone
- +82 7052276000
- Auditors
- Echon Accounting Corp.
Upcoming Events for 214610
The BioMed Co Ltd Extraordinary Shareholders Meeting
Q2 2025 MiCo BioMed Co Ltd Earnings Release
Similar to 214610
Access Bio
Korea Exchange - KOSDAQ
Aligned Genetics
Korea Exchange - KOSDAQ
Alphanox Co
Korea Exchange - KOSDAQ
Angel Robotics Co
Korea Exchange - KOSDAQ
Asta Co
Korea Exchange - KOSDAQ
FAQ
What is the The BioMed Co share price?
As of Today at 23:39 UTC, shares in The BioMed Co are trading at KR₩4,385. This share price information is delayed by 15 minutes.
How has the The BioMed Co share price performed this year?
Shares in The BioMed Co last closed at KR₩4,385 and the price had moved by -70.53% over the past 365 days. In terms of relative price strength the The BioMed Co share price has underperformed the FTSE Developed Asia Pacific Index by -70.45% over the past year.
What are the analyst and broker recommendations for The BioMed Co?
There is no consensus recommendation for this security.
Find out moreWhat is the The BioMed Co dividend yield?
The BioMed Co does not currently pay a dividend.
Does The BioMed Co pay a dividend?
The BioMed Co does not currently pay a dividend.
When does The BioMed Co next pay dividends?
The BioMed Co does not currently pay a dividend.
How do I buy The BioMed Co shares?
To buy shares in The BioMed Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of The BioMed Co?
As of the previous close price of KR₩4,385, shares in The BioMed Co had a market capitalisation of KR₩23bn.
Where are The BioMed Co shares listed?
Here are the trading details for The BioMed Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 214610
What kind of share is The BioMed Co?
Based on an overall assessment of its quality, value and momentum The BioMed Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a The BioMed Co share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the The BioMed Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like The BioMed Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -75.21%.
As of the last closing price of KR₩4,385, shares in The BioMed Co were trading -68.54% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the The BioMed Co PE Ratio?
The The BioMed Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩4,385.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of The BioMed Co?
We do not have data on The BioMed Co's directors